Hormonal contraceptives and hair dyes increase breast cancer risk

March 9, 2017

In her recent doctoral dissertation, researcher Sanna Heikkinen from the University of Helsinki and Finnish Cancer Registry evaluates the contribution of the use of hormonal contraceptives and hair dyes to the spectrum of breast cancer risk factors.

The analysis included self-reported survey data from 8000 breast cancer patients and 20 000 controls from Finland.

According to the results, use of hormonal intrauterine device was associated with 52% increased risk of breast cancer in post-menopausal women, when compared to women who had used copper intrauterine device.

The use of other hormonal contraceptives was, by contrast, associated with 32% higher among younger women under 50 when compared to women who did not use hormonal contraceptives.

There was also a 23% observed increase in the risk of breast cancer among women who dyed their hair compared to those who didn't.

To confirm the roles of these factors, further research on the effects of , most specifically hormonal intrauterine device, and hair dyes is needed with other populations and a prospective study design.

"The biggest risk factor in is high age, and known lifestyle-related risk factors include late age at first birth, small number of children, high alcohol consumption, and sedentary lifestyle," Heikkinen stresses.

Many of these factors have become significantly more common in Western countries, including Finland, during the last decades.

In her research, Heikkinen also investigated the amount of opportunistic mammography, which was found to be very common. More than 60% of responders reported having had a mammography before the screening age of 50.

"Women should be more extensively informed of the harms of opportunistic mammography, such as accumulating radiation burden and the potential consequences of false positive or negative findings," Heikkinen says.

Explore further: Low thromboembolism risk for contraceptive use in diabetes

Related Stories

Low thromboembolism risk for contraceptive use in diabetes

December 6, 2016
(HealthDay)—For women with diabetes who are using hormonal contraception, the absolute risk of thromboembolism is low, with the lowest rates seen with use of intrauterine and subdermal contraceptives, according to a study ...

Hormonal contraception may raise depression risk

September 29, 2016
(HealthDay)—Women who use hormonal methods for birth control may have a higher risk of developing depression—and teenagers may be most vulnerable, according to a study published online Sept. 28 in JAMA Psychiatry.

False-positive mammography results are common

January 12, 2016
(HealthDay)—For women undergoing digital mammography screening, false-positive results are common, especially among younger women and those with risk factors, according to research published online Jan. 12 in the Annals ...

Potential effects of fertility treatments on breast density and cancer risk

April 13, 2016
Infertility and hormonal fertility treatments may influence the amount of dense tissue in the breast, a risk factor for breast cancer, according to a study involving 43,313 women, published in the open access journal Breast ...

Long-term use of hormonal contraceptives is associated with an increased risk of brain tumors

January 22, 2015
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain. This project focussed on women aged 15 -49 years and ...

Obesity is risk factor for rare type of stroke in women using oral contraceptives

March 14, 2016
Obese women who used oral contraceptives appeared to have increased risk for a rare type of stroke known as a cerebral venous thrombosis (CVT) compared with women of normal weight who did not use oral contraceptives, according ...

Recommended for you

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

One in five young colon cancer patients have genetic link

December 13, 2017
As doctors grapple with increasing rates of colorectal cancers in young people, new research from the University of Michigan may offer some insight into how the disease developed and how to prevent further cancers. Researchers ...

New strategy for unleashing cancer-fighting power of p53 gene

December 13, 2017
Tumor protein p53 is one of the most critical determinants of the fate of cancer cells, as it can determine whether a cell lives or dies in response to stress. In a new study published today in the journal Nature Communications, ...

Researchers develop test that can diagnose two cancer types

December 12, 2017
A blood test using infrared spectroscopy can be used to diagnose two types of cancer, lymphoma and melanoma, according to a study led by Georgia State University.

Cancer-causing mutation suppresses immune system around tumours

December 12, 2017
Mutations in 'Ras' genes, which drive 25% of human cancers by causing tumour cells to grow, multiply and spread, can also protect cancer cells from the immune system, finds a new study from the Francis Crick Institute and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.